Opinion

Video

Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia

Author(s):

Daniel E. Kremens, MD, JD

An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content
NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging
March 12th 2025

NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging

Isabella Ciccone, MPH Tanya Simuni, MD, FAAN
Multisymptomatic Care in Parkinson's Disease
September 4th 2024

Multisymptomatic Care in Parkinson's Disease

Stuart H. Isaacson, MD, FAAN Rajesh Pahwa, MD Jennifer G. Goldman, MD, MS
FDA Approves Medtronic’s Adaptive Deep Brain Stimulation for Parkinson Disease
February 24th 2025

FDA Approves Medtronic’s Adaptive Deep Brain Stimulation for Parkinson Disease

Marco Meglio
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
April 9th 2024

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
NeuroVoices: Sheryll Baltazar, NP-C, on AI Integration and Emerging Therapies in Neurology
February 19th 2025

NeuroVoices: Sheryll Baltazar, NP-C, on AI Integration and Emerging Therapies in Neurology

Sheryll Baltazar, NP-C Isabella Ciccone, MPH
Julie Pilitsis, MD, PhD, MBA (Credit: The University of Arizona)
February 10th 2025

Optimizing Parkinson Disease Care With Newly Approved Continuous Infusion Therapy

Julie Pilitsis, MD, PhD, MBA Isabella Ciccone, MPH
© 2025 MJH Life Sciences

All rights reserved.